Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. TDOC
TDOC logo

TDOC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
5.575
Open
5.540
VWAP
5.46
Vol
1.58M
Mkt Cap
993.67M
Low
5.355
Amount
8.63M
EV/EBITDA(TTM)
6.02
Total Shares
178.40M
EV
1.21B
EV/OCF(TTM)
4.10
P/S(TTM)
0.39
Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.
Show More

Events Timeline

No data

No data

News

Benzinga
9.5
03-10Benzinga
PinnedTeladoc Health Reports Stronger-Than-Expected Quarterly Results
  • Quarterly Performance Exceeds Expectations: Teladoc Health reported a quarterly loss of $0.14 per share, better than the expected loss of $0.18, with sales reaching $642.27 million, surpassing the forecast of $635.24 million, driven by a 24% increase in other revenue streams despite a 4% decline in access fees revenue.
  • Cautious Future Outlook: The company expects a first-quarter 2026 loss between $0.35 and $0.45, with sales projected at $598 million to $620 million, both below consensus estimates of $0.25 and $633.75 million, indicating challenges in the current economic environment.
  • Analyst Rating Changes: Deutsche Bank upgraded Teladoc from Hold to Buy with a price target of $11, reflecting confidence in the company's valuation; however, BTIG maintained a Neutral rating, expressing caution due to market competition and macroeconomic conditions despite acknowledging decent quarterly results.
  • Stock Price Analysis: Teladoc shares are currently trading at $5.59, 21.8% above the 20-day simple moving average but 12.5% below the 100-day moving average, indicating short-term strength while facing long-term pressures, with a 40.65% decline over the past 12 months.
Fool
6.5
03-10Fool
Union Square Capital Sells Entire Stake in Mohawk Industries
  • Share Sale Details: Union Square Park Capital Management disclosed in an SEC filing that it sold its entire 40,000-share position in Mohawk Industries during Q4 2026, with the previous stake valued at $5.1 million, representing 1.8% of its reported assets.
  • Market Performance Analysis: Mohawk Industries' stock is currently priced at $132.60, reflecting a 9.6% increase over the past year, yet it remains 62% below its previous peak, indicating struggles for growth in a weak housing market.
  • Financial Overview: Mohawk Industries reported a TTM revenue of $10.8 billion and a net income of $369.9 million, with a market capitalization of $8.2 billion, showcasing its strong position in the global flooring market, although management noted a 3% year-over-year revenue decline last quarter.
  • Investment Strategy Shift: Following the sale of its Mohawk stake, Union Square increased its investment in RH, indicating a strategic shift in seeking undervalued stocks and potentially better return prospects in other investments.
Newsfilter
9.5
03-10Newsfilter
Teladoc Health Stock Soars After Beating Earnings Estimates
  • Earnings Beat: Teladoc Health's latest earnings report exceeded market expectations, leading to a stock price surge that reflects the company's strong performance and sustained demand in the telehealth sector.
  • Cautious 2026 Guidance: Despite robust current results, the company has adopted a cautious outlook for 2026, which may impact investor confidence and necessitate close monitoring of future market dynamics and strategic adjustments.
  • Mixed Analyst Views: Analysts have divergent opinions on Teladoc's prospects, with some maintaining optimistic ratings while others express reservations about future growth, potentially leading to stock price volatility.
  • Positive Market Reaction: Despite the cautious long-term guidance, the positive investor response to the company's current performance indicates that the market remains optimistic about Teladoc's long-term potential in the telehealth industry, which may attract more capital inflows.
stocktwits
6.0
03-10stocktwits
Deutsche Bank Upgrades Teladoc to Buy with $11 Price Target
  • Rating Upgrade: Deutsche Bank upgraded Teladoc from Hold to Buy with a price target of $11, representing a 107% upside from Monday's closing price of $5.3, indicating strong confidence in Teladoc's current valuation.
  • Positive Market Reaction: Teladoc's shares surged over 10% in pre-market trading on Tuesday, and if this level holds, the stock could open at its highest price since January 26, 2026, reflecting optimistic investor sentiment regarding the company's future prospects.
  • Acquisition Impact: The acquisition of Talkspace by UHS, expected to close in Q3 2026, is viewed by Deutsche Bank as a “clear positive for Teladoc,” potentially providing a roadmap for a future exit scenario and enhancing its market position.
  • Investor Sentiment Shift: Retail sentiment on Stocktwits shifted from bearish to bullish over the past 24 hours, with users expressing that Teladoc's market value is undervalued, showcasing confidence in the company's growth potential.
seekingalpha
6.0
03-10seekingalpha
Deutsche Bank Upgrades Teladoc to Buy, Citing Valuation and Growth Prospects
  • Rating Upgrade: Deutsche Bank upgraded Teladoc from Hold to Buy, with analyst George Hill citing a compelling valuation and improving prospects for the BetterHelp business, which is expected to drive stock price appreciation.
  • Business Outlook: Although BetterHelp has been shrinking, Teladoc has a stabilization and growth plan in place, and the analyst believes this will provide long-term growth potential, maintaining a price target of $11.
  • Market Performance: Teladoc's stock has declined over 40% in the past 12 months and is rated Hold on Wall Street, indicating market caution regarding its future performance.
  • Future Projections: Teladoc projects revenue between $2.47 billion and $2.59 billion for 2026 while advancing AI, insurance, and international growth, demonstrating the company's strategic intent for diversified development.
CNBC
6.0
03-10CNBC
Latest Wall Street Rating Updates
  • BofA Downgrades Qualcomm: Bank of America has downgraded Qualcomm from neutral to underperform with a price target of $145, citing lukewarm projected sales and EPS growth of only 2% and 1% CAGR from 2025 to 2028, significantly lagging the semiconductor sector's expected 17% growth.
  • Deutsche Bank Upgrades Teladoc: Deutsche Bank upgraded Teladoc from hold to buy, highlighting an attractive risk/reward profile due to compelling valuation and a deliverable strategy for its BetterHelp business, indicating a strong potential for future growth.
  • TD Cowen Upgrades Rivian: TD Cowen upgraded Rivian from hold to buy, projecting full-scale demand for its R2 model to reach between 212,000 and 335,000 units, suggesting significant upside potential against 2027 consensus estimates.
  • Morgan Stanley Reiterates Microsoft Overweight: Morgan Stanley reiterated its overweight rating on Microsoft, emphasizing the readiness of its Office product suite for the upcoming Agentic AI offerings, with general availability expected on May 1, 2026, priced at $99 per user per month.
Wall Street analysts forecast TDOC stock price to rise
15 Analyst Rating
Wall Street analysts forecast TDOC stock price to rise
3 Buy
12 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
7.50
Averages
8.91
High
12.00
Current: 0.000
sliders
Low
7.50
Averages
8.91
High
12.00
Deutsche Bank
George Hill
Hold
to
Buy
upgrade
$11
AI Analysis
2026-03-10
New
Reason
Deutsche Bank
George Hill
Price Target
$11
AI Analysis
2026-03-10
New
upgrade
Hold
to
Buy
Reason
Deutsche Bank analyst George Hill upgraded Teladoc to Buy from Hold with an $11 price target.
BofA
Buy
maintain
$7
2026-03-10
New
Reason
BofA
Price Target
$7
2026-03-10
New
maintain
Buy
Reason
BofA raised the firm's price target on Teladoc (TDOC) to $8.25 from $7 and keeps a Buy rating on the shares. Universal Health Services' (UHS) agreement to acquire Talkspace (TALK) for $5.25 per share is "a clear positive for Teladoc" that provides "further support that the market is undervaluing Teladoc's virtual therapy business as well as the rest of Teladoc," the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for TDOC
Unlock Now

Valuation Metrics

The current forward P/E ratio for Teladoc Health Inc (TDOC.N) is -7.68, compared to its 5-year average forward P/E of -26.64. For a more detailed relative valuation and DCF analysis to assess Teladoc Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-26.64
Current PE
-7.68
Overvalued PE
-2.19
Undervalued PE
-51.08

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
24.91
Current EV/EBITDA
5.36
Overvalued EV/EBITDA
51.47
Undervalued EV/EBITDA
-1.65

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.91
Current PS
0.49
Overvalued PS
6.48
Undervalued PS
-0.66

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what are some day trades i can do with 300$
Intellectia · 122 candidates
Region: USPrice: $1.00 - $30.00Price Change Pct: $3.00 - $100.00Relative Vol: >= 1.50Beta: HighRiskList Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
UWMC logo
UWMC
UWM Holdings Corp
6.66B
PATH logo
PATH
UiPath Inc
5.32B
AAL logo
AAL
American Airlines Group Inc
8.80B
OPEN logo
OPEN
Opendoor Technologies Inc
4.77B
RGTI logo
RGTI
Rigetti Computing Inc
5.82B
LUNR logo
LUNR
Intuitive Machines Inc
3.23B

Whales Holding TDOC

T
Tang Capital Management, LLC
Holding
TDOC
+3.59%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Teladoc Health Inc (TDOC) stock price today?

The current price of TDOC is 5.445 USD — it has decreased -2.24

What is Teladoc Health Inc (TDOC)'s business?

Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.

What is the price predicton of TDOC Stock?

Wall Street analysts forecast TDOC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TDOC is8.91 USD with a low forecast of 7.50 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Teladoc Health Inc (TDOC)'s revenue for the last quarter?

Teladoc Health Inc revenue for the last quarter amounts to 642.27M USD, increased 0.28

What is Teladoc Health Inc (TDOC)'s earnings per share (EPS) for the last quarter?

Teladoc Health Inc. EPS for the last quarter amounts to -0.14 USD, decreased -50.00

How many employees does Teladoc Health Inc (TDOC). have?

Teladoc Health Inc (TDOC) has 5600 emplpoyees as of March 11 2026.

What is Teladoc Health Inc (TDOC) market cap?

Today TDOC has the market capitalization of 993.67M USD.